Answers are grounded in this paper and cite their sources.
This work represents the first broad study of testing diverse heterogenous glycoconjugates (7 different glycoalbumins) for their differential in vivo binding (11 different cancer cell types) in both cell- and animal-based studies. As a result, various changes in biodistribution, excretion, and even tumor adhesion were observed.
No takes yet. Share an insight, caveat, or question.
Ogura et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: